Home > BIGG > Search result

    Results: 3

    Chinese Guidelines related to Novel Coronavirus Pneumonia

    Qiu, Tingting; Liang, Shuyao; Dabbous, Monique; Wang, Yitong; Han, Ru; Toumi, Mondher.
    China has managed to control the coronavirus disease (COVID-19) with confinement measurements and treatment strategies, while other countries are struggling to contain the spread. This study discussesthe guidelines related to COVID-19 in China in order to provide important references for other countries ...
    Betacoronavirus/drug effects, Pneumonia, Viral/epidemiology, Coronavirus Infections/epidemiology, China/epidemiology, Pandemics/prevention & control, Pandemics/statistics & numerical data, Epidemiological Monitoring, Health Information Management/methods, Interferons/therapeutic use, Lopinavir/therapeutic use, Ritonavir/therapeutic use, Ribavirin/therapeutic use, Chloroquine/therapeutic use, Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy
    Fulltext

    Australian guidelines for the clinical care of people with COVID-19 - Australian National COVID-19 Clinical Evidence Taskforce

    National COVID-19 Clinical Evidence Taskforce.
    This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
    Clinical Diagnosis/diagnosis, Betacoronavirus/drug effects, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Hypoxia/diagnosis, Patient Acuity, Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Dexamethasone/therapeutic use, Breast Feeding, Antiviral Agents/therapeutic use, Hydroxychloroquine/therapeutic use, Colchicine/therapeutic use, Plasma/immunology, Darunavir/therapeutic use, Interferons/therapeutic use, Evidence-Based Practice/methods
    Fulltext